Mostrar el registro sencillo del ítem

Autordc.contributor.authorAppiania, Franco
Autordc.contributor.authorAbara, Belén
Autordc.contributor.authorRamírez, Iván
Autordc.contributor.authorAndrade, Christian
Autordc.contributor.authorMelo, Joel
Autordc.contributor.authorBarra, Fernando
Autordc.contributor.authorVerdugo, Fernando Javier
Autordc.contributor.authorRossel Mariángel, Víctor
Autordc.contributor.authorLim, Jongsung
Autordc.contributor.authorDonoso, Erika
Autordc.contributor.authorArrué, Urania
Autordc.contributor.authorRiquelme, María Paz
Fecha ingresodc.date.accessioned2025-01-22T13:18:26Z
Fecha disponibledc.date.available2025-01-22T13:18:26Z
Fecha de publicacióndc.date.issued2025
Cita de ítemdc.identifier.citationTransplantation Proceedings, 000, 1−6 (2025)es_ES
Identificadordc.identifier.otherhttps://doi.org/10.1016/j.transproceed.2024.11.034
Identificadordc.identifier.urihttps://repositorio.uchile.cl/handle/2250/203005
Resumendc.description.abstractIntroduction. Whether the implementation of a multimodal prehabilitation program is effective and safe for high-risk heart or lung transplantation candidates, whose condition prevents hospital discharge, is unclear. Methods. We conducted a retrospective study at a cardiothoracic transplant center in Chile. Two cohorts of hospitalized patients listed for heart or lung transplant were studied: the first underwent traditional (historical) and nonstructured prehabilitation, and the second underwent protocol-driven multimodal prehabilitation (MP). Adverse events and preoperative functional changes in the MP group were documented, as well as comparative postoperative outcomes between both cohorts. Results. Between 2018 and 2023, 24 transplant recipients were analyzed. During the MP phase, significant improvement was observed in Medical Research Council scale (52.0 § 7to 58.7 § 3; P = .042), sit-to-stand test (7.1 § 7 to 15.9 § 6; P = .018), and euthymic state (from 4 to 10 patients; P .036), without reported adverse events. Postoperatively, MP group demonstrated faster standing (1.9 § 0.7 vs 1.3 § 0.5 days; P = .05) and sitting times (2.0 § 0.7 vs 1.2 § 0.5 days; P = .007), with more early extubations (3 vs 11; P = .003) in comparison to the historical prehabilitation cohort. Conclusion. In this small retrospective study, MP in hospitalized patients awaiting heart or lung transplantation appears to be safe and associated with improvements in pre- and postoperative outcomes.es_ES
Idiomadc.language.isoenes_ES
Publicadordc.publisherElsevieres_ES
Tipo de licenciadc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
Link a Licenciadc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
Fuentedc.sourceTransplantation Proceedingses_ES
Palabras clavesdc.subjectHeart transplantationes_ES
Palabras clavesdc.subjectLung transplantationes_ES
Palabras clavesdc.subjectLatin Americaes_ES
Títulodc.titleMultimodal inpatient prehabilitation prior to heart or lung transplantation in a latin american transplant reference centeres_ES
Tipo de documentodc.typeArtículo de revistaes_ES
dc.description.versiondc.description.versionVersión aceptada para publicar - Postprintes_ES
dcterms.accessRightsdcterms.accessRightsAcceso abiertoes_ES
Catalogadoruchile.catalogadorlajes_ES
Indizaciónuchile.indexArtículo de publicación WoSes_ES


Descargar archivo

Icon

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivs 3.0 United States
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivs 3.0 United States